Table 3.
Patient category∗ | Level | Cancer-specific death⁎⁎ |
HR (95% CI)⁎⁎⁎ | P-value | Interaction term |
|
---|---|---|---|---|---|---|
Radiation | No radiation | P-value # | ||||
Cancer-directed surgery | No cancer-directed surgery | 312/424 | 2194/2614 | 0.61 [0.54, 0.69] | <.0001 | .002 |
Tumor resection | 82/166 | 361/816 | 1.00 [0.79, 1.27] | .73 | ||
Ablation | 3/5 | 28/53 | 0.66 [0.20, 2.19] | .46 | ||
Age | <70 y | 282/429 | 1555/2189 | 0.72 [0.63,0.81] | <.0001 | .37 |
≥70 y | 118/170 | 1060/1337 | 0.66 [0.54, 0.79] | <.0001 | ||
Sex | Female | 204/316 | 1282/1770 | 0.66 [0.57, 0.77] | <.0001 | .55 |
Male | 196/283 | 1333/1756 | 0.71 [0.61,0.82] | <.0001 | ||
T stage | T0 | 0/2 | 11/11 | - | - | .99 |
T1 | 111/196 | 747/1139 | 0.71 [0.58, 0.87] | .0008 | ||
T2 | 93/157 | 580/845 | 0.71 [0.57, 0.88] | .002 | ||
T3 | 100/122 | 551/668 | 0.72 [0.58, 0.89] | .003 | ||
T4 | 59/76 | 289/370 | 0.65 [0.49, 0.87] | .003 | ||
N stage | N0 | 240/389 | 1645/2332 | 0.68 [0.60, 0.78] | <.0001 | .91 |
N1 | 128/175 | 666/845 | 0.65 [0.53, 0.78] | <.0001 | ||
M stage | M0 | 256/424 | 1367/2057 | 0.73 [0.64, 0.84] | <.0001 | .73 |
M1 | 144/175 | 1248/1469 | 0.76 [0.64, 0.90] | .002 |
Note:
Patient category∗: patients were categorized by diagnosis time (2004–2009, 2010–2013) and N0 / N1 stages. N0 category included patients with no lymph node metastasis, while N1 category included patients with lymph node metastasis.
Cancer-specific death⁎⁎ was demonstrated as ICC-specific death number (numerator) divided by number of patients treated by radiation/no radiation in each patients category∗ with or without primary tumor surgery.
HR (95% CI)∗∗∗ showed the hazard ratio (95% confidence interval) of cancer-specific death among radiation patients vs no radiation patients in subgroups.
P-value # for interaction term indicated the different effect of radiation among stratified subgroups.